Hansen's Disease
What's New
Last Posted: Mar 08, 2023
- Genomic Reduction at TTC Repeats in the Bacterial Genome of Treated Cases of Hansen's Disease: A Possible Survival Mechanism of Mycobacterium leprae.
Reja Abu Hena Hasanoor, et al. Indian journal of dermatology 2018 0 (6) 449-454 - A Study on the Impact of Genetic Polymorphisms of Cytokines TNF?, IFN? and IL10 in South Indian Leprosy Patients.
Kolla Venkata Karunakar, et al. Indian journal of dermatology 0 0 (2) 138-144 - Cytokine gene polymorphisms in type I and type II reactions in Hansen's disease.
Pragasam Vijendran, et al. Indian journal of dermatology, venereology and leprology 2020 5 - Polymorphisms in genes TLR1, 2 and 4 are associated with differential cytokine and chemokine serum production in patients with leprosy.
Santana Nadja de Lima, et al. Memorias do Instituto Oswaldo Cruz 2017 4 (4) 260-268 - The -308 bp TNF gene polymorphism influences tumor necrosis factor expression in leprosy patients in Bahia State, Brazil.
Oliveira Joyce Moura, et al. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2016 1 - Examining ERBB2 as a candidate gene for susceptibility to leprosy (Hansen's disease) in Brazil.
Araújo Sérgio Ricardo Fernandes, et al. Memórias do Instituto Oswaldo Cruz 2014 4 (2) 182-8 - Protein tyrosine phosphatase non-receptor type 22 gene polymorphism C1858T is not associated with leprosy in Azerbaijan, Northwest Iran.
Aliparasti Mohammad Reza, et al. Indian journal of human genetics 2013 10 (4) 403-7 - Leprosy (Hansen's Disease)
- Hansen's disease
From NCATS Genetic and Rare Diseases Information Center - Missense mutations of the interleukin-12 receptor beta 1(IL12RB1) and interferon-gamma receptor 1 (IFNGR1) genes are not associated with susceptibility to lepromatous leprosy in Korea.
Lee Seong-Beom, et al. Immunogenetics 2003 6 (3) 177-81
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: